237 related articles for article (PubMed ID: 23935377)
1. Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study.
Usharani P; Fatima N; Muralidhar N
Diabetes Metab Syndr Obes; 2013; 6():275-84. PubMed ID: 23935377
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the effects of a standardized aqueous extract of Phyllanthus emblica fruits on endothelial dysfunction, oxidative stress, systemic inflammation and lipid profile in subjects with metabolic syndrome: a randomised, double blind, placebo controlled clinical study.
Usharani P; Merugu PL; Nutalapati C
BMC Complement Altern Med; 2019 May; 19(1):97. PubMed ID: 31060549
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Phyllanthus emblica extract on cold pressor induced cardiovascular changes in healthy human subjects.
Fatima N; Pingali U; Pilli R
Pharmacognosy Res; 2014 Jan; 6(1):29-35. PubMed ID: 24497739
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive and pleiotropic effects of Phyllanthus emblica extract as an add-on therapy in patients with essential hypertension-A randomized double-blind placebo-controlled trial.
Shanmugarajan D; Girish C; Harivenkatesh N; Chanaveerappa B; Prasanna Lakshmi NC
Phytother Res; 2021 Jun; 35(6):3275-3285. PubMed ID: 33570228
[TBL] [Abstract][Full Text] [Related]
5. Effect of an aqueous extract of Terminalia chebula on endothelial dysfunction, systemic inflammation, and lipid profile in type 2 diabetes mellitus: A randomized double-blind, placebo-controlled clinical study.
Pingali U; Sukumaran D; Nutalapati C
Phytother Res; 2020 Dec; 34(12):3226-3235. PubMed ID: 32618037
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia.
Upadya H; Prabhu S; Prasad A; Subramanian D; Gupta S; Goel A
BMC Complement Altern Med; 2019 Jan; 19(1):27. PubMed ID: 30670010
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of Emblica Officinalis Gatertn (Amla) in healthy human subjects: Health benefits and safety results from a randomized, double-blind, crossover placebo-controlled study.
Kapoor MP; Suzuki K; Derek T; Ozeki M; Okubo T
Contemp Clin Trials Commun; 2020 Mar; 17():100499. PubMed ID: 31890983
[TBL] [Abstract][Full Text] [Related]
8. Study of pharmacodynamic interaction of Phyllanthus emblica extract with clopidogrel and ecosprin in patients with type II diabetes mellitus.
Fatima N; Pingali U; Muralidhar N
Phytomedicine; 2014 Apr; 21(5):579-85. PubMed ID: 24291054
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of Amla (Phyllanthus emblica L.) in non-erosive reflux disease: a double-blind, randomized, placebo-controlled clinical trial.
Karkon Varnosfaderani S; Hashem-Dabaghian F; Amin G; Bozorgi M; Heydarirad G; Nazem E; Nasiri Toosi M; Mosavat SH
J Integr Med; 2018 Mar; 16(2):126-131. PubMed ID: 29526236
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Effect of Fish Oil Alone and in Combination with a Proprietary Chromium Complex on Endothelial Dysfunction, Systemic Inflammation and Lipid Profile in Type 2 Diabetes Mellitus - A Randomized, Double-Blind, Placebo-Controlled Clinical Study.
Pingali U; Nutalapati C; Illendulla VS
Diabetes Metab Syndr Obes; 2020; 13():31-42. PubMed ID: 32021349
[TBL] [Abstract][Full Text] [Related]
11. Tannoid principles of Emblica officinalis attenuated aluminum chloride induced apoptosis by suppressing oxidative stress and tau pathology via Akt/GSK-3βsignaling pathway.
Justin Thenmozhi A; Dhivyabharathi M; Manivasagam T; Essa MM
J Ethnopharmacol; 2016 Dec; 194():20-29. PubMed ID: 27566203
[TBL] [Abstract][Full Text] [Related]
12. Emblica officinalis and its enriched tannoids delay streptozotocin-induced diabetic cataract in rats.
Suryanarayana P; Saraswat M; Petrash JM; Reddy GB
Mol Vis; 2007 Jul; 13():1291-7. PubMed ID: 17679931
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Effect of an Aqueous Extract of
Pingali U; Ali MA; Gundagani S; Nutalapati C
Diabetes Metab Syndr Obes; 2020; 13():4401-4412. PubMed ID: 33244247
[TBL] [Abstract][Full Text] [Related]
14. The effects of garlic extract upon endothelial function, vascular inflammation, oxidative stress and insulin resistance in adults with type 2 diabetes at high cardiovascular risk. A pilot double blind randomized placebo controlled trial.
Atkin M; Laight D; Cummings MH
J Diabetes Complications; 2016; 30(4):723-7. PubMed ID: 26954484
[TBL] [Abstract][Full Text] [Related]
15. Metabolomic Analysis and Antioxidant Effect of Amla (Emblica officinalis) Extract in Preventing Oxidative Stress-Induced Red Cell Damage and Plasma Protein Alterations: An In Vitro Study.
Packirisamy RM; Bobby Z; Panneerselvam S; Koshy SM; Jacob SE
J Med Food; 2018 Jan; 21(1):81-89. PubMed ID: 29064307
[TBL] [Abstract][Full Text] [Related]
16. Antidiabetic and antioxidant potential of Emblica officinalis Gaertn. leaves extract in streptozotocin-induced type-2 diabetes mellitus (T2DM) rats.
Nain P; Saini V; Sharma S; Nain J
J Ethnopharmacol; 2012 Jun; 142(1):65-71. PubMed ID: 22855943
[TBL] [Abstract][Full Text] [Related]
17. Emblica officinalis improves glycemic status and oxidative stress in STZ induced type 2 diabetic model rats.
Ansari A; Shahriar MS; Hassan MM; Das SR; Rokeya B; Haque MA; Haque ME; Biswas N; Sarkar T
Asian Pac J Trop Med; 2014 Jan; 7(1):21-5. PubMed ID: 24418077
[TBL] [Abstract][Full Text] [Related]
18. Studies on effects of Emblica officinalis (Amla) on oxidative stress and cholinergic function in scopolamine induced amnesia in mice.
Golechha M; Bhatia J; Arya DS
J Environ Biol; 2012 Jan; 33(1):95-100. PubMed ID: 23033650
[TBL] [Abstract][Full Text] [Related]
19. Amla (Emblica officinalis Gaertn.) extracts reduce oxidative stress in streptozotocin-induced diabetic rats.
Rao TP; Sakaguchi N; Juneja LR; Wada E; Yokozawa T
J Med Food; 2005; 8(3):362-8. PubMed ID: 16176148
[TBL] [Abstract][Full Text] [Related]
20.
Patil BS; Kanthe PS; Reddy CR; Das KK
Cardiovasc Hematol Agents Med Chem; 2019; 17(1):52-63. PubMed ID: 30963985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
